Globus Medical Q1 Revenue Jumps 27% to $759.9M on Spine Growth, Nevro Deal
The medical device maker raised full-year EPS guidance to $4.70-$4.80 after strong U.S. spine sales and margin expansion. Globus Medical reported first-quarter revenue of $759.9 million, up 27% year over year, driven by U.S. spine momentum, margin expansion, and contributi